From admission to vaccination: COVID-19 vaccination patterns and their relationship with hospitalization in trauma patients

被引:1
|
作者
Rafaqat, Wardah [1 ]
Abiad, May [1 ]
Lagazzi, Emanuele [1 ]
Argandykov, Dias [1 ]
Velmahos, George C. [1 ]
Hwabejire, John O. [1 ]
Parks, Jonathan J. [1 ]
Luckhurst, Casey M. [1 ]
Kaafarani, Haytham M. A. [1 ]
DeWane, Michael P. [1 ]
机构
[1] Massachusetts Gen Hosp, Div Trauma Emergency Gen Surg & Surg Crit Care, Cambridge, MA USA
关键词
FRAILTY; OUTCOMES;
D O I
10.1016/j.surg.2023.11.025
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: COVID-19 vaccination rates in the hospitalized trauma population are not fully characterized and may lag behind the general population. This study aimed to outline COVID-19 vaccination trends in hospitalized trauma patients and examine how hospitalization influences COVID-19 vaccination rates. Methods: We conducted a retrospective institutional study using our trauma registry paired with the COVID-19 vaccination ENCLAVE registry. We included patients >18 years admitted between April 21, 2021 and November 30, 2022. Our primary outcome was the change in vaccination posthospitalization, and secondary analyzed outcomes included temporal trends of vaccination in trauma patients and predictors of non-vaccination. We compared pre and posthospitalization weekly vaccination rates. We performed joinpoint regression to depict temporal trends and multivariate regression for predictors of nonvaccination. Results: The rate of administration of the first vaccine dose increased in the week after hospitalization (P = .018); however, this increase was not sustained in the following weeks. The percentage of unvaccinated patients declined faster in the general population in Massachusetts compared to the hospitalized trauma population. By the conclusion of the study, 27.1% of the trauma population was unvaccinated, whereas <5% of the Massachusetts population was unvaccinated. Urban residence, having multiple hospitalizations, and experiencing moderate to severe frailty were associated with vaccination. Conversely, being in the age groups 18 to 45 years and 46 to 64 years, as well as having Medicaid or self- pay insurance, were linked to being unvaccinated. Conclusion: Hospitalization initially increased the rate of administration of the first vaccine dose in trauma patients, but the effect was not sustained. By the conclusion of the study period, a greater percentage of trauma patients were unvaccinated compared to the general population of Massachusetts. Strategies for sustained health care integration need to be developed to address this ongoing challenge in the high-risk trauma population.
引用
收藏
页码:1212 / 1216
页数:5
相关论文
共 50 条
  • [31] COVID-19 vaccination: the VOICE for patients with cancer
    van der Veldt, Astrid A. M.
    Oosting, Sjoukje F.
    Dingemans, Anne-Marie C.
    Fehrmann, Rudolf S. N.
    GeurtsvanKessel, Corine
    Jalving, Mathilde
    Rimmelzwaan, Guus F.
    Kvistborg, Pia
    Blank, Christian U.
    Smit, Egbert F.
    Lemmens, Valery E. E. P.
    Hiltermann, T. Jeroen N.
    Koopmans, Marion P. G.
    Huckriede, Anke L. W.
    Rots, Nynke Y.
    van Els, Cecile A. C. M.
    van Baarle, Debbie
    Haanen, John B. A. G.
    de Vries, Elisabeth G. E.
    NATURE MEDICINE, 2021, 27 (04) : 568 - 569
  • [32] COVID-19 Vaccination in Hemodialysis Patients Correspondence
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2022, 29 (03) : 311 - 311
  • [33] Patients With Myocarditis Associated With COVID-19 Vaccination
    Rosner, Carolyn M.
    Atkins, Melany
    Saeed, Ibrahim M.
    de Lemos, James A.
    Khera, Amit
    Maghsoudi, Alireza
    Min, Jean
    Tehrani, Behnam N.
    O'Connor, Christopher M.
    deFilippi, Christopher R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (13) : 1317 - 1319
  • [34] COVID-19, impact of vaccination in myeloma patients
    Hoornaert, Ellen
    Dachy, Francois
    Hansenne, Amandine
    Lagneaux, Eugenie
    Gruson, Damien
    Bailly, Sarah
    Vekemans, Marie
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S116 - S116
  • [35] COVID-19 vaccination for patients with primary immunodeficiency
    Roifman, Chaim M.
    Vong, Linda
    LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS, 2021, 8 (02): : 37 - 45
  • [36] COVID-19 vaccination: the VOICE for patients with cancer
    Astrid A. M. van der Veldt
    Sjoukje F. Oosting
    Anne-Marie C. Dingemans
    Rudolf S. N. Fehrmann
    Corine GeurtsvanKessel
    Mathilde Jalving
    Guus F. Rimmelzwaan
    Pia Kvistborg
    Christian U. Blank
    Egbert F. Smit
    Valery E. E. P. Lemmens
    T. Jeroen N. Hiltermann
    Marion P. G. Koopmans
    Anke L. W. Huckriede
    Nynke Y. Rots
    Cecile A. C. M. van Els
    Debbie van Baarle
    John B. A. G. Haanen
    Elisabeth G. E. de Vries
    Nature Medicine, 2021, 27 : 568 - 569
  • [37] Impact of COVID-19 vaccination in patients with epilepsy
    Elshebawy, Haidy
    Kishk, Nirmeen A.
    Alaa, Nouran
    Hussein, Mona
    Abdelghaffar, Mohamed
    Magdy, Rehab
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2024, 60 (01):
  • [38] COVID-19 vaccination in patients with immune thrombocytopenia
    Visser, Chantal
    Swinkels, Maurice
    van Werkhoven, Erik D.
    Croles, F. Nanne
    Noordzij-Nooteboom, Heike S.
    Eefting, Matthijs
    Last-Koopmans, Suzanne M.
    Idink, Cecile
    Westerweel, Peter E.
    Santbergen, Bart
    Jobse, Pieter A.
    Baboe, Fazil
    Te Boekhorst, Peter A. W.
    Leebeek, Frank W. G.
    Levin, Mark-David
    Kruip, Marieke J. H. A.
    Jansen, A. J. Gerard
    BLOOD ADVANCES, 2022, 6 (06) : 1637 - 1644
  • [39] COVID-19: impact of vaccination in myeloma patients
    E. Hoornaert
    F. Dachy
    A. Hansenne
    S. Bailly
    A. van Maanen
    D. Gruson
    M-C. Vekemans
    Annals of Hematology, 2022, 101 : 1607 - 1608